Konstantinos Evangelou

Konstantinos Evangelou

Auto-generated profile, based on publicly available information

Konstantinos Evangelou

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School National and Kapodistrian University of Athens Athens Greece

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2011 in Journal of Cell Biology
Verified
Journal Article
Open access
MSMaria Sideridou
Maria Sideridou
RZRoubini Zakopoulou
Roubini Zakopoulou
KEKonstantinos Evangelou
Konstantinos Evangelou
MLMichalis Liontos
Michalis Liontos
AKAthanassios Kotsinas
Athanassios Kotsinas
Vassilis GorgoulisVassilis Gorgoulis
Vassilis Gorgoulis
E-cadherin (CDH1) loss occurs frequently in carcinogenesis, contributing to invasion and metastasis. We observed that mouse and human epithelial cell lines overexpressing the replication licensing factor Cdc6 underwent phenotypic changes with mesenchymal features and loss of E-cadherin. Analysis in various types of human cancer revealed a strong correlation between increased Cdc6 expression and reduced E-cadherin levels. Prompted by these findings, we discovered that Cdc6 repressed CDH1 transcription by binding to the E-boxes of its promoter, leading to dissociation of the chromosomal insulator CTCF, displacement of the histone variant H2A.Z, and promoter heterochromatinization. Mutational analysis identified the Walker B motif and C-terminal region of Cdc6 as essential for CDH1 transcriptional suppression. Strikingly, CTCF displacement resulted in activation of adjacent origins of replication. These data demonstrate that Cdc6 acts as a molecular switch at the E-cadherin locus, linking transcriptional repression to activation of replication, and provide a telling example of how replication licensing factors could usurp alternative programs to fulfill distinct cellular functions.

7 August 2023 in The Journal of Pathology
Verified
Journal Article
Open access
KEKonstantinos Evangelou
Konstantinos Evangelou
KBKonstantinos Belogiannis
Konstantinos Belogiannis
APAngelos Papaspyropoulos
Angelos Papaspyropoulos
RPRussell Petty
Russell Petty
Vassilis GorgoulisVassilis Gorgoulis
Vassilis Gorgoulis
Cellular senescence constitutes a stress response mechanism in reaction to a plethora of stimuli. Senescent cells exhibit cell‐cycle arrest and altered function. While cell‐cycle withdrawal has been perceived as permanent, recent evidence in cancer research introduced the so‐called escape‐from‐senescence concept. In particular, under certain conditions, senescent cells may resume proliferation, acquiring highly aggressive features. As such, they have been associated with tumour relapse, rendering senescence less effective in inhibiting cancer progression. Thus, conventional cancer treatments, incapable of eliminating senescence, may benefit if revisited to include senolytic agents. To this end, it is anticipated that the assessment of the senescence burden in everyday clinical material by pathologists will play a crucial role in the near future, laying the foundation for more personalised approaches. Here, we provide an overview of the investigations that introduced the escape‐from‐senescence phenomenon, the identified mechanisms, as well as the major implications for pathology and therapy. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.